Obesity drugs show early promise against common hormonal disorder
GLP-1 medications are showing early promise in treating a hormonal disorder that affects one in eight women worldwide.
Obesity drugs known as GLP-1s are demonstrating early potential in treating a common hormonal disorder. One family has reported that using the medications has given them hope after dealing with the condition, which affects a significant proportion of women globally.
Covered by1NewsNot covered byRNZStuffNZ HeraldNewstalk ZBOtago Daily TimesNewsroomThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
1News
Obesity drugs show early promise against common hormonal disorder
One family said using GLP-1s have given them hope after suffering with the disorder affecting 1 in 8 women worldwide.